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ABSTRACT
The recently discovered clustered regularly
interspaced short palindromic repeat (CRISPR)-
mediated virus defense represents an adaptive
immune system in many bacteria and archaea.
Small CRISPR RNAs cause cleavage of complemen-
tary invading nucleic acids in conjunction with an
associated protein or a protein complex. Here, we
show CRISPR-mediated cleavage of mRNA from an
invading virus in the hyperthermophilic archaeon
Sulfolobus solfataricus. More than 40% of the
targeted mRNA could be cleaved, as demonstrated
by quantitative polymerase chain reaction. Cleavage
of the mRNA was visualized by northern analyses
and cleavage sites were mapped. In vitro, the
same substrates were cleaved by the purified
CRISPR-associated CMR complex from Sulfolobus
solfataricus. The in vivo system was also re-
programmed to knock down mRNA of a selected
chromosomal gene (b-galactosidase) using an arti-
ficial miniCRISPR locus. With a single complemen-
tary spacer, 50% reduction of the targeted mRNA
and of corresponding intracellular protein activity
was achieved. Our results demonstrate in vivo
cleavage of mRNA in a prokaryote mediated by
small RNAs (i.e. analogous to RNA interference in
eukaryotes) and the re-programming of the system
to silence specific genes of interest.
INTRODUCTION
RNA interference represents one of the many
sophisticated mechanisms of gene regulation in eukaryotes
and can also act against invading viruses and other genetic
elements (1). Recently, an adaptive immune system has
been described in bacteria and archaea that also acts
through small RNAs. These clustered regularly
interspaced short palindromic repeat RNAs (crRNAs)
are encoded in CRISPR regions in the genomes that
harbor short but mostly unique DNA sequences
(spacers) separated by repeats (2). On transcription, the
crRNAs are cleaved from the long primary transcript, so-
called precursor CRISPR RNA (pre-crRNA), in the
repeat sequences and form ribonucleoprotein complexes
with CRISPR-associated (Cas) protein(s) (3–7). These
are able to target and cleave invading DNA molecules
that exhibit complementarity to the guide crRNA
(8–10). Acquisition of additional spacer sequences from
newly invading viruses or plasmids allows adaptation of
the immune system and inheritance to progeny cells
(8,11–14). A huge variety of the CRISPR-Cas systems
(2) has been found in 50% of all bacterial genomes
and 90% of the archaeal genomes (15). In vivo activity
has been demonstrated in six model systems of bacteria
and in three model organisms of archaea, proving the
effective CRISPR-mediated immunity against DNA of
invading viruses or plasmids by type I, type II and type
IIIA CRISPR systems (5,8,16–22). Furthermore, the type
II system (17) has recently been used to efﬁciently recog-
nize and cleave speciﬁc genes in a programmable dual-
RNA manner (9) that functions independently and can
be used in various bacteria and eukaryotes to generate
targeted mutations (23–26). The same system was also
engineered to repress gene expression in a bacterium
by directing a protein to the promoter to physically
block transcription initiation (26,27). Interestingly, some
evidence has accumulated that CRISPR-Cas systems can
not only target DNA but also RNA molecules. In vitro
studies in the two hyperthermophilic archaea Pyrococcus
furiosus (28,29) and Sulfolobus solfataricus (30) have
demonstrated that crRNAs in association with the so-
called CMR protein complex encoded in a type IIIB
CRISPR-Cas module speciﬁcally lead to cleavage of
*To whom correspondence should be addressed. Tel: +43 14277 76510; Fax: +4314277 876510; Email: christa.schleper@univie.ac.at
yThese authors contributed equally to the paper as ﬁrst authors.
5280–5288 Nucleic Acids Research, 2014, Vol. 42, No. 8 Published online 6 March 2014
doi:10.1093/nar/gku161
 The Author(s) 2014. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which
permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
 at St A
ndrew
s U
niversity Library on July 9, 2014
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
RNA targets but not DNA. More recently, a type II
CRISPR-Cas module was shown to mediate bacterial
virulence and immune invasion by affecting mRNA ex-
pression (31), but whether mRNA was degraded or tran-
scription was physically blocked was not investigated.
We and others have recently established an in vivo study
system for the hyperthermophilic archaeon S. solfataricus
that allowed characterizing CRISPR-mediated DNA
interference of plasmid and virus DNA (18,19). Strains
of S. solfataricus possess a rather complex and extended
CRISPR-Cas assembly with ﬁve Cas modules classiﬁed
into the CRISPR-Cas system types I, type IIIA and IIIB
(2,32). With the help of our shuttle-vector system that is
based on the lysogenic virus SSV1, we have recently
demonstrated that DNA interference can be abolished
when there is complementarity between the repeat-
derived 50-handle of the crRNA and the protospacer
adjacent sequence (PAS) on the virus (33). This mechan-
ism that obviously protects the host from degradation of
its own genome was earlier shown in the bacterium
Staphylococcus epidermidis (16). Even complementarity
of only three nucleotides between handle and PAS
enabled self-recognition in Sulfolobus, i.e. abolished
DNA interference (33). In this study, we use this know-
ledge to shut-off DNA interference in S. solfataricus and
demonstrate CRISPR-mediated cleavage of speciﬁc
mRNAs in vivo. Cleaved mRNA products are visualized
and in vivo cleavage sites are mapped. We also re-program
the RNA interference system such that it can be used to
speciﬁcally target the mRNA of chromosomal genes.
MATERIALS AND METHODS
Sulfolobus cultures and transfection procedure
Cultures of S. solfataricus M18 [pyrEF mutant of
S. solfataricus P1 (34)] were grown at 78C and pH 3
in basic Brock media (35) and supplemented with
enzymatically hydrolyzed casein, i.e. tryptone (BD
Biosciences) 0.1% (w/v) and (+) D-Sucrose at 0.2%
(w/v). For growth of the uracil auxotrophic mutant
M18, uracil at a ﬁnal concentration of 0.0125mg/ml was
added to the media. Electro-competent cells were prepared
as previously described (36) and transfected by electropor-
ation using the following conditions: 1250V, 1000V,
25mF and 1-mm cuvettes (37,38). Cultures transfected
with D63-7U, D63-HA and A53* were mixed with
untransfected M18 cells in Brock salts containing 0.4%
gellan gum (Gelrite, Kelco Biopolymers) for plaque
assay on Brock media-containing plates (19). Between 20
and 150 plaques were obtained per biological replicate
(each having three technical replicates). Therefore,
plaque-forming efﬁciency is expressed as % of positive
control (A53*).
After transfection, cells were grown in selective media
(without uracil) to OD (600 nm)=1. Cells were then
inoculated into tryptone (BD Biosciences) 0.1% (w/v)
media with a reduced sucrose concentration (0.04%)
until OD (600)=0.2–0.3. Expression of the protospacer
constructs D63-7U, D63-HA and A53* (control) was
induced through the addition of 20% (m/v) arabinose
(0.16% ﬁnal concentration). After 4 h, samples of the
cultures were taken for DNA and RNA extraction.
In each experiment, at least three biological replicates
were sampled and analyzed.
Nucleic acid preparations
DNA extractions from S. solfataricus cells were performed
with a basic phenol-chloroform extraction with TENS and
TENST (39) as lysis buffers. The entire extracted DNA
was treated with RNase (Omega, bio-tek) before further
analysis. Isolation of total RNA was done with the
mirVanaTM kit (Ambion), followed by DNAseI treat-
ment (PromegaTM), following manufacturer’s instruc-
tions. RNA quality and purity were measured by
NanoDrop (ND-1000, PeqLab) and agarose gel electro-
phoresis, respectively. Absence of DNA contamination in
the RNA preparation was veriﬁed by polymerase chain
reaction (PCR) ampliﬁcation of 100 ng of DNAse I-
treated RNA before further analysis. The cDNA
reaction was carried out using 1 mg of RNA and M-
MuLV Reverse Transcriptase (New England, Bio Labs)
following the manufacturer’s instructions. The cDNA was
then puriﬁed using columns (NucleoSpin, Macherey-
Nagel) and was used after dilution to 20 ng/ml for real-
time PCR quantiﬁcation.
Construction of recombinant viruses
General cloning techniques
For RNAi constructs, a protospacer sequence identical to
the D63 crRNA (located in the CRISPR locus D of
S. solfataricus strain P2 and P1) was placed into ORF
406 of the conjugative plasmid pNOB8 (19). The
pNOB8 ORF406 was cloned into the gateway entry
vector pCR8-GW (Supplementary Figure S3) following
the manufacturer’s recommendations (InvitrogenTM,
TOPO-TA cloning), yielding pEntryA53* (with match to
spacer A53 in strain P2 but no match in strain P1). The
recombinant plasmid was further mutated using the
Overlapping Extension-PCR (OE PCR) method [see fol-
lowing text and (40)] to replace the protospacer A53* by
new protospacer sequences matching the crRNA of spacer
D63. To maintain the open reading frame of ORF 406,
two additional nucleotides were added 50-ﬂanking to the
protospacer (TC, marked in yellow in Supplementary
Figure S3). The resulting plasmids (pEntry D63-7U
and pEntryD63-HA) were veriﬁed by sequencing.
Subsequently, they were used in a gateway recombination
reaction with the destination vector pDEST-MJ-ara
(Supplementary Figure S4A, consisting of the gateway re-
combination sites, an arabinose-inducible promoter (41)
and a terminator region (42) implemented into the
S. solfataricus–Escherichia coli shuttle vector pMJ03),
yielding vectors pMZ-D63-7U, pMZ-D63-HA and pMZ-
A53*. For the miniCRISPR constructs, a 900-bp region of
CRISPR D locus was ampliﬁed from the S. solfataricus P2
genome including 497 bp of the leader sequence of the
CRISPR locus, six repeats and six spacers (D2 was
replaced by a nonsense spacer in the miniCRISPR
control). After cloning into the pCR8-GW vector
yielding pEntry NBG, OE-PCR was used to replace
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three spacers (D2, D3 and D4) by a spacer matching the b-
galactosidase mRNA at position D2 (BG-HA) (yielding
vector pI2). Both miniCRISPR constructs (entry vectors
pI2 with spacer BG and pEntryNBG without the BG spa-
cer) were recombined with the destination vector pDEST-
MJ (without ara promoter). A scheme of the destination
vectors is shown in Supplementary Figure S4.
Construct design: OE PCR
OE PCRs were applied for construction of the different
virus variants. The OE fragments for D63-U7 and D63-
HA were produced by using four partly complementary
primers, carrying the desired protospacer sequences
ﬂanked by 50 nt homologous to the plasmid sequence
on both sites of insertion. To create the OE fragment,
the overlapping primers were fused by PCR, using a
proofreading polymerase (Phusion DNA polymerase,
Finnzyme). For construction of the miniCRISPR con-
struct pI2, six primers were used in the fusion reaction.
In the ﬁrst two PCRs, the OE primers (MOE-FW and
MOE-RW) were fused with the spacer-speciﬁc primers,
yielding two short PCR fragments. In the successive
PCR, the two fragments were then fused together
and ampliﬁed using the primers M-FW and M-RW
(Supplementary Tables S2 and S3). Owing to thermo-
dynamic reasons, the OE primers MOE-FW and MOE-
RW were not designed on proximal spacers. For this
reason, the miniCRISPR-BG-HA lacks spacer D2, D3
and D4 compared with the control but it retains spacer
D1, D5 and D6. The OE fragments were used in a ratio of
200:1 as primers in a PCR reaction using 30 ng of the entry
vectors pEntryA53* and pEntryNBG, as a template. After
ampliﬁcation, the PCR reaction was digested with DpnI
(FermentasTM) to cleave the non-mutated circular
plasmid. The digested PCR reaction was directly used to
transform E. coli (TOP10, InvitrogenTM). All recombinant
plasmids were veriﬁed by standard Sanger sequencing.
Quantitative PCR
Each real-time quantitative polymerase chain reaction
(qPCR) was performed in triplicate with a SYBR-
Green mix (QiagenTM) on an Eppendorf Mastercycler ep
gradient S realplex2 (Eppendorf). Two primer sets were
designed and used for the qPCR analyses of D63 con-
structs and in the miniCRISPR experiment for quantiﬁca-
tion of b-galactosidase mRNA. Primer set Q1 ampliﬁed
the region of the target site (protospacer) in the ORF406
and b-galactosidase mRNA (i.e. measuring the amount of
mRNA that remained uncut), and set Q2 ampliﬁed a
region located toward the 50 end not covering the target
site (i.e. approximating the totally expressed mRNA level).
This approach was used because it avoided any effects of
varying virus copy numbers on the gene expression meas-
urements that would have confused results if another
mRNA was quantiﬁed in the control. Primers and
product sizes are given in Supplementary Tables S2 and
S3. Plasmids pEntryA53* and pMJ03-05 were used as
qPCR standards, and ampliﬁcation PCR efﬁciencies
ranged between 94 and 99% on the template ORF406
and between 92 and 102% for the b-galactosidase gene.
Three biological replicates with three technical replicates
each were performed for each experiment. The relative
quantiﬁcation on ORF406 transcripts (D63-7U and
D63-HA) was calculated using Q1 products (covering
the protospacer, region of cleavage) over total mRNA
obtained by Q2 primers compared with the control
A53*, using qPCR normalization methods separately for
each replica (43). The relative quantiﬁcation of the
miniCRISPR-BG-HA constructs was performed using
two control samples: miniCRISPR-control and pMZ-
A53* (two tailed t-test shows no signiﬁcant differences
between miniCRISPR-control and pMZ-A53*, with
P=0.2199 and P=0.2698 for tryptone and tryptone/
arabinose, respectively). The relative quantiﬁcation was
calculated by the same principle as mentioned earlier
using the primer pairs BG-Q1 and BG-Q2. Signiﬁcance
values, average and SD for ORF406 and b-galactosidase
are shown in Figures 1C and 2B, respectively.
Rapid ampliﬁcation of cDNA ends
Extracted total RNA from the RNAi constructs 406-7U
and 406-HA was treated with DNAseI (PromegaTM), and
endpoint PCR was performed to determine absence/
presence of remaining DNA. About 1 mg of the treated
RNA was polyadenylated with an E. coli Poly(A) poly-
merase (New England, Bio LabsTM). The polyadenylated
RNA was used in a reverse transcription reaction
(M-MuLV Reverse Transcriptase, New England, Bio
LabsTM) with a poly(T) primer. After retrotranscription,
the cDNA was ampliﬁed with primer 406-FW3 and
a poly(T) primer (57C annealing temperature), with
Phusion DNA polymerase (Finnzymes). The PCR
product was successively puriﬁed by agarose gel
electrophoresis (Macherey-Nagel) and cloned into a pJet
cloning vector (FermentasTM). In all, 25 different clones
from D63-7U and 18 for D63-HA were sequenced by
standard Sanger sequencing using the primer Q1-FW.
Northern blot analysis
Total RNA (2.5–10mg) was denatured for 10min at 65C
before separation on a 1% formaldehyde gel (80V, 6 h).
After transfer to nylon membrane by capillary blotting
(Membrane Hybond-XL, Amersham), the RNA was
cross-linked with UV light. The RNA was visualized with
0.4% methylene blue and ladder position was determined.
Hybridization was performed with a digoxigenin-labeled
(DIG-labeled) dsDNA probe obtained through a PCR
reaction with DIG-labeled dNTPs (Roche). Primers in the
PCR reaction were Pro-FW1 and Pro-RW2, amplifying
333 nt, at the 50-end upstream of the protospacer region,
not covering the protospacer (Supplementary Table S3).
The hybridization was done overnight at 42C. Three strin-
gent washing steps were made for 30min each with 0.2%
SSC/0.1% SDS at 55C, 60C and 65C. Probe/mRNA
hybrids were detected with DIG antibody (Roche) and
chemiluminescence reaction with CSPD solution (Roche).
Different amounts of total RNA were loaded for the blot
shown in Figure 1B and Supplementary Figure S5 (2.5mg
for A53*, 10mg for D63-7U and 5mg for D63-HA) to allow
visualization of the cleavage product of D63-7U.
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Preparation of crude protein extract
In all, 10ml (OD600=0.3–0.4) of transfected
S. solfataricus M18 cell culture was harvested before and
after supplement of arabinose (as mentioned earlier) by
centrifugation at 4000 rpm for 15min at 4C. Cells were re-
suspended in 700 ml of 10mM Tris-HCl buffer, pH 8, and
sonicated (Bandelin SONOPULS HD2070, 3 1min on
ice, 40% duty cycle). After sonication, cell debris were
removed by centrifugation at 15 000 rpm for 30min at
4C. Cell-free extract (supernatant) was collected and
stored at 80C until use. Protein concentrations of the
different cell extracts were determined using the Bradford
method with serum albumin as standard, all in triplicate.
b-Galactosidase activity assay
Quantitative b-galactosidase assays were carried out to
assess the activity of b-galactosidase in the crude cell
extracts. Activity was measured by following the enzymatic
hydrolysis of o-nitrophenyl-b-D-galactoside to galactose
and o-nitrophenol, and was quantiﬁed spectrophotometric-
ally. In all, 50ml of cell-free extract was added to 950ml of
o-nitrophenyl-b-D-galactoside solution (0.84mg/ml in
50mM sodium phosphate buffer, pH 6.5) and incubated
at 75C for 5min. The release of o-nitrophenol was
then measured spectrophotometrically at 405nm with inter-
vals of 30 s, and b-galactosidase activity (mU/mg) of the
different cell extracts was determined using the Lambert–
Beer law, as described earlier (36). Protein expression
ratios were calculated by dividing the b-galactosidase
activity (mU/mg) of the sample (miniCRISPR-BG-HA)
by the b-galactosidase activity of the control sample
(miniCRISPR-control), which was set to one. Three biolo-
gical replicates were performed. Signiﬁcance values,
average and SD are shown in Figure 2C.
In vitro RNA cleavage assay
In vitro RNA cleavage assays were carried out as
described previously (30). In brief, 500 nM puriﬁed
SsoCMR complex and 100 nM unlabeled crRNA (D63
crRNA) were mixed in buffer [20mM Mes.HCl pH 6.0,
100mM glutamate, 10mM DTT, 10mM MnCl2 and the
RNase inhibitor SUPERase.in (Ambion)] in the presence
or absence of 100mMATP and pre-incubated at room tem-
perature for 10min before the addition of 500nM 50-32P-
end-labeled synthetic target RNA to the reaction mix (10ml
total volume). The reaction was further incubated at 75C
for 10min, then stopped with EDTA and analyzed by gel
electrophoresis and phosphor imaging.
Oligonucleotides for in vitro RNA cleavage assay
RNA oligonucleotides were chemically synthesized
(Integrated DNA Technologies). The D63 crRNA guide
sequence shown here differs by one base from that used
previously (30). The original Zhang et al. sequence had an
extra A at position 32 that was introduced by error. This
difference has no effect on the cleavage activity observed.
The sequences are:
crD63: 50-AUUGAAAGUUUCGUAUAAGGACCAG
AACGGCAAUACCCAAACUGU-30
D63-7U: 50-CGAAUCAAUAGUUUGGGUAUUGUU
GUUUUGGUUUUUAUAUGAAAGAGAGC-30
D63-HA: 50-AUAGUUUGGGUAUUGUUGUUUUG
GUUUUUAUAUGAAACUUUCAAUGAG-30
crBG-HA: 50-AUUGAAAGAUGUUAUACAUAUGC
CUACGGGAAAGUUCAAAGCUUAGG-30
BG-HA: 50-CCUAAGCUUUGAACUUUCCCGUAGG
CAUAUGUAUAACAUCAUUCAAG-30
RESULTS AND DISCUSSION
In our previous work, we have demonstrated that the
CRISPR system in S. solfataricus can recognize and
trigger degradation of a protospacer located on viral
DNA. This study also showed that the efﬁciency of
plaque formation decreases with an increasing number
of mismatches between spacer and protospacer (19,33).
Here, the system was modiﬁed to circumvent CRISPR-
mediated DNA cleavage to study RNA interference. For
this purpose, a protospacer was used as a target on the
viral DNA that was complementary to crRNA D63
encoded on locus 6 (or D) (44). This crRNA had been
shown earlier to be the most prominent crRNA recruited
into the CMR complex that is able to degrade RNA
in vitro (30). Seven point mutations were introduced into
the DNA target of virus D63-7U that led to T:G
mismatches in a DNA:RNA hybrid but allowed U:G
pairing in the corresponding RNA duplex (Figure 1). In
construct D63-HA (=HAndle), we have additionally
introduced a stretch of 8 nt at the 30 end of the protospacer
called the PAS. This exhibited complementarity to the 8-nt
‘handle’ of the 50 end of the crRNA. The 8-nt-long
50-handle, which is derived from the ﬂanking repeat in
the chromosome, has been shown to remain attached to
the crRNAs on their maturation from the initially
produced pre-crRNA (16,28). As shown earlier for the
type IIIA system in Staphylococcus epidermidis (16), com-
plementarity between handle and PAS abolished DNA
interference also in our system (33).
The gene with the respective protospacer was expressed
from the virus under the control of an arabinose-inducible
promoter. After transfection of DNA and subsequent
plaque assays, only around 62% of plaques were
observed for construct D63-7U as compared with the
control A53* (Table 1). Apparently, seven G-U mismatches
in D63-7U allowed the virus to escape the host’s CRISPR
system. This effect was sufﬁcient for the virus, such that it
could stably establish as a population in liquid culture
under selective conditions. In contrast, construct D63
(20% plaque formation) could not survive as a population
in culture, even under selective conditions and was not
further characterized (Table 1). But more remarkably,
no signiﬁcant DNA degradation was observed anymore
for construct D63-HA, which in addition to the seven
mutations in its protospacer sequence matched the
50-handle of the crRNA (92% plaque formation). The ob-
servation conﬁrmed our earlier ﬁndings, that CRISPR
DNA interference modules in the host are circumvented
almost completely by a perfectly matching PAS that is com-
plementary to a part of the repeat in the CRISPR locus
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Figure 1. CRISPR-mediated RNA interference of a non-essential gene introduced into S. solfataricus P1 via a recombinant virus. (A) Schematic
representation of virus constructs (top) and chromosomal CRISPR locus with cognate spacer (bottom), as well as respective transcripts (wiggly lines)
and their degradation (interrupted lines) A53*=negative control with non-matching protospacer, D63-7U=seven U:G pairs in RNA:RNA
protospacer/spacer hybrid (light blue/dark blue), D63-HA=additional 8-nt 50-handle matching the repeat-derived crRNA part. Para=arabinose-
inducible promoter. (B) Northern blot hybridization showing mRNA cleavage from cells transfected with A53*, D63-7U and D63-HA. Arrow
indicates cleavage product. Upper band corresponds to full-length mRNA. (C) Results of qPCR showing amounts of mRNA (with primer set Q1
covering the protospacer region; Figure 1A and Supplementary Table S3) over total mRNA (primer set Q2) after reverse transcription of total RNA
into cDNA. Lowercase letters indicate signiﬁcant differences in relative mRNA expression (two-tailed t-test, n 3, P 0.028). Error bars, SD; (n 3).
(D) Protospacer/spacer pairs as in (A), capital letters mark complementary bases, lowercase letters mark mismatches, triangles mark cut sites as
mapped in vivo by RACE (black, Supplementary Figure S1) and in vitro by incubating both RNAs with the CMR complex of S. solfataricus P2
(white triangles, Supplementary Figure S2A) (30).
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and, therefore, also complementary to the 50-handle of the
crRNA (33).
We used qPCR on reverse-transcribed total RNA to
analyze the amount of cleaved mRNA with two speciﬁc
primer pairs. The ﬁrst PCR product (Q1 in Figure 1)
covered the region of the protospacer (that was expected
to be cleaved, i.e. the target) and the second one covered
an upstream region closer to the transcription start of the
same respective gene (the reference template). The latter
region was not a direct target of the RNA interference
and should thus allow an estimate on the total mRNA
level of the same gene. As a negative control, RNA
from transformants with a protospacer (A53*) was used
that did not have a cognate spacer in the chromosome of
strain S. solfataricus P1 (but only in the closely related
strain S. solfataricus P2).
The amount of cleaved over uncleaved mRNA is shown
in Figure 1C after normalizing it to the ratio of qPCR
products obtained from cDNA of the control (A53*).
Approximately 42% of mRNA cleavage was observed
with the D63-HA construct and 26% with D63-
7U (Figure 1C). We assumed that the lower level of cut
mRNA in construct D63-7U was because of the shorter
mRNA-crRNA hybrid formation, as the protospacer
D63-7U is lacking the 8-nt sequence compared with the
construct D63-HA that has a perfectly matching PAS to
the crRNA D63, expanding the target from 37 nt to 45 nt.
Because there was still signiﬁcant DNA interference with
construct D63-7U, we assumed that the lower level of
RNA interference was also caused by the overall lower
level of virus DNA in the respective culture. This was
conﬁrmed by qPCR studies estimating virus DNA levels
in the culture (Supplementary Table S1B).
For conﬁrmation of in vivo RNA cleavage mediated by
the crRNA D63, northern blot analysis (Figure 1B)
and rapid ampliﬁcation of cDNA ends (RACE) were per-
formed to visualize and map the cleavage sites (Figure 1D
and Supplementary Figure S1). Beside the uncut full-
length mRNA that was the only band in the northern
hybridization detected in the control, an additional
smaller band of the size expected for mRNA cut in the
protospacer site was detected for D63-7U and D63-HA
transfectants, whose abundance was in accordance with
that measured by qPCR (Figure 1C and Supplementary
Table S1A). The 30 end of the mRNA (downstream of the
protospacer) could not be visualized in northern analyses
probably because of fast degradation in the cell. More
accurate lengths of the cut mRNA species generated
through RNA interference in the transformed cells were
determined in RACE experiments. About two-thirds of all
cut sites in D63-HA and D63-7U transfectants were
mapped inside the protospacer regions of the mRNA or
in close vicinity, i.e. 3 nt inside the region of the 8-nt
handle region, with an accumulation of mRNA ending
at AU and UU sites (Figure 1D and Supplementary
Figure S1). Other mRNA ends (10 of 25 for D63-7U
and 6 of 18 for D63-HA) were located toward the 50end
of the full mRNA, indicating more progressively degraded
products (from 30 to 50 direction). No cuts were located by
RACE beyond the protospacer toward the 30 end of the
full mRNA, strongly supporting the conclusion that initial
cutting of the mRNA occurred inside the protospacer and
then progressed toward the 50 end.
Cleavage of mRNA in vitro
To explore if the sequence-speciﬁc RNA cleavage
observed for the D63-7U and D63-HA targets could be
ascribed to the crRNA-dependent ribonuclease activity of
the CMR complex, in vitro assays were performed as
described earlier (30). The CMR complex in S. solfataricus
has seven different subunits including the large Cas10
subunit and cuts in vitro at U/A sites in a reaction that
is dependent on manganese and stimulated by ATP (30).
The catalytic site of the complex has not yet been
determined. A similar CMR system is found in
euryarchaea, including P. furiosus (28,29). This version
of the complex lacks the Cmr7 subunit found in
S. solfataricus CMR and appears to cleave RNA using a
different mechanism that includes a molecular ruler. By
contrast, the CSM complex shares the Cas10 subunit but
is known to cleave plasmid DNA substrates in vivo (10,16).
Small RNAs of D63-7U and D63-HA were synthesized
and radiolabeled and their cleavage was assayed in vitro
using puriﬁed CMR complex of S. solfataricus. Both sub-
strates were cleaved by the CMR complex in the presence
of the crRNA D63, as expected, but not in its absence
(Figure 1D and Supplementary Figure S2A). These data
conﬁrm our in vivo results and show that the CMR
complex does not have an absolute requirement for a
mismatch opposite the 50-handle. Interestingly, in vitro
cleavage of the D63-HA substrate was not stimulated by
ATP, whereas cleavage of the other substrate was, which
is presumably due to the effect of complete base pairing
between the 50-handle of the crRNA D63 and the D63-HA
target (Figure 1D).
The in vivo mapped cutting sites (by RACE, Figure 1D)
did not all overlap with those from the in vitro assay. This
might be explained by the subsequent exonucleolytic deg-
radation of mRNA that occurs only in vivo or by slightly
suboptimal conditions chosen for the in vitro assay.
Programming the system for targeted transcriptional
silencing
To investigate if CRISPR-mediated RNA interference can
also be programmed to degrade mRNA of speciﬁc chromo-
somal genes, artiﬁcial miniCRISPR loci with and without a
spacer targeting the mRNA of b-galactosidase (b-gal) were
constructed and expressed in S. solfataricus. The CRISPR
leader region, the repeats and the spacers stemmed from
locus D (44) of the same organism. An additional b-gal-
Table 1. Plaque-forming units normalized to the control A53*
Construct Average (in %) SD (in %)
D63-DNA 19.3 13.5
D63-7U 62.1 1.3
D63-HA 91.6 8.0
A53* 100 0
n=three biological replicates, with each n=three technical replicates,
SD=standard deviation.
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speciﬁc spacer of 39nt was designed such that it hybridized
to a region in the mRNA of b-gal whose eight adjacent
nucleotides exhibited complementarity to the repeat-
derived 50-handle of the crRNA (construct miniCRISPR-
BG-HA, Figure 2A and D). This construct thus followed
the same principle to suppress DNA interference as used in
D63-HA earlier. It exhibited only two mismatches within
the 8-nt sequence, which was still sufﬁcient to fully suppress
DNA interference, as shown in (33). On transfection of
S. solfataricus with the recombinant virus and a control
virus with the same miniCRISPR locus but lacking spacer
BG-HA, cells were split and grown in two different sugar-
containing media that yielded different amounts of b-gal
mRNA in the cells. Figure 2B displays the amount of
Figure 2. Programmed CRISPR-mediated RNA interference of a chromosomal gene from S. solfataricus using a recombinant virus carrying an
artiﬁcial miniCRISPR locus. (A) Schematic representation of miniCRISPR construct with spacer BG-HA targeting the b-Gal gene (SSO3019) in
nucleotide positions 679–717, with eight ﬂanking nucleotides exhibiting complementarity to the 8-nt 50-handle. Locations of primers used in qPCR
(BG1 and BG2) are indicated (B) Quantitative PCR estimating the relative amounts of mRNA (with primer set BG-Q1 covering the protospacer
region) over total mRNA (primer set BG-Q2) after reverse transcription of total RNA. Signiﬁcant differences in relative mRNA expression between
miniCRISPR-BG-HA and control in tryptone and tryptone/arabinose media are represented in capital letters or lowercase letters, respectively
(two-tailed t-test, n 3, P 0.004). Error bars, SD (n 3). (C) Signiﬁcant differences in relative b-gal enzyme activity between miniCRISPR-
BG-HA and control in both media are represented in capital letters or lowercase letters, respectively (two-tailed t-test, n 3, P< 0.00001). Error
bars, SD; (n 3). (D) Protospacer region in mRNA and 50-handle and its complement (crRNA). Capital letters: complementarity, lowercase letters:
mismatches, triangles: cut sites mapped in vitro by incubating both RNAs with the CMR complex of S. solfataricus P2 plus ATP (Supplementary
Figure S2B) (30).
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b-gal mRNA compared with that of the control, as
estimated by qPCR. The cells were grown in tryptone
media and rich media (tryptone/arabinose) that induce
slightly different absolute mRNA levels in the culture
(3-fold higher with arabinose). Depending on the
growth medium, 52% (tryptone media) and 41%
(tryptone/arabinose media) of b-gal mRNA was found
for BG-HA compared with the control cells. In line with
this ﬁnding, between 45 and 49% of relative protein activity
was detected in crude extracts of the same cell preparations,
demonstrating that the gene was effectively silenced under
both growth conditions. Similar levels of mRNA cleavage
as seen here have been obtained earlier in eukaryotes. For
example, between 50 and 75% of the mRNA level was
decreased in human breast cancer cell lines by using a
variety of small RNAs, endogenous micro RNA and
small interfering RNA or exogenous micro RNA mimics
and duplex RNA (45). Again we demonstrated a crRNA-
dependent cutting of the mRNA at UA and UU sites by the
CMR complex in vitro (Figure 2D and Supplementary
Figure S2B).
CONCLUSION
Our experiments conﬁrm CRISPR-mediated RNA-cleavage
as suggested earlier through in vitro results with puriﬁed
CMR complexes in two different archaea (28,30). We dem-
onstrate here in addition that the RNA interference can
be programmed in vivo to target mRNA degradation of a
speciﬁc chromosomal gene. Thus, CRISPR-mediated RNA
interference can be used in this archaeon and probably
many other bacteria and archaea to downregulate chromo-
somal genes on the post-transcriptional level via a CMR
complex. Our data point to the possibility that the
CRISPR system might generally interfere with gene expres-
sion in its host. It also implicates interesting applications in
future research to investigate the function of essential genes
in archaea and bacteria, provided that DNA targeting can
be abolished. We assume that the use of several spacers
targeted to the same gene will increase the silencing effect
to higher levels than observed here. For this purpose, the
use of a Sulfolobus strain solely expressing a CMR-like
CRISPR type would be most suitable. Our system as well
as the recently demonstrated programmable repression
systems in bacteria (26,27) might become interesting add-
itions to the genetic toolboxes of bacteria and archaea in the
future. Furthermore, detailed studies of the underlying
mechanism of RNA interference in vivo and of the effects
of RNA interference on virus propagation are now
becoming possible.
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Supplementary Data are available at NAR Online.
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